Study Links Biological Age Gap to Lower Stroke Risk and Brain Health

Research indicates that narrowing the gap between biological age and chronological age may significantly reduce the risk of stroke and improve brain health. A preliminary study published in the journal Stroke and set to be presented at the American Academy of Neurology’s 78th Annual Meeting from April 18 to 22, 2026, in Chicago highlights this potential connection.

While the study does not establish a direct cause-and-effect relationship, it reveals noteworthy associations. The research team, led by Dr. Cyprien Rivier from Yale University, emphasizes the importance of understanding how biological age can impact overall health. “It’s exciting to think that working to modify our biological age could be a pathway to preserving brain health,” Dr. Rivier noted.

To conduct this extensive study, researchers analyzed the biological age of 258,169 individuals using a health care research database. They assessed 18 biomarkers in the blood, including cholesterol levels and red blood cell volume, to establish biological age at the start and again six years later for a subset of participants.

Over an average follow-up period of ten years, the researchers tracked stroke occurrences and evaluated cognitive functions through memory and thinking skills tests, alongside brain scans for signs of damage. Initially, participants exhibited an average biological age of 54 years, compared to their chronological age of 56. After six years, biological age increased to 58, while the actual age rose to 62.

Those with a biological age exceeding their chronological age demonstrated less favorable brain scans and poorer cognitive test scores by the end of the study. Additionally, they faced a 41% increased risk of stroke. Conversely, participants who successfully improved their biological age gap during the study saw a 23% reduction in stroke risk during the follow-up period. Furthermore, these individuals exhibited a 13% decrease in the volume of white matter hyperintensities, which indicate damage to brain tissue.

Researchers accounted for various factors influencing stroke risk and brain damage, including hypertension and socioeconomic status. Dr. Rivier stressed the need for further investigation into whether actively reducing the biological age gap can lead to meaningful improvements in stroke risk and cognitive health.

Despite the promising associations, the study’s limitations are noteworthy. While it identified significant links, the design was not intended to prove causality. Additionally, the smaller group that underwent repeat blood tests restricts definitive conclusions about longitudinal changes, especially concerning cognitive assessments. The findings are summarized in the abstract titled “Improvements in Biological Age Acceleration Lead to Better Neuroimaging, Clinical, and Cognitive Markers of Brain Health”, authored by Dr. Rivier and colleagues.

As the research community continues to explore this relationship, the potential implications for public health and preventative strategies are substantial, particularly as the global population ages.